- Home
- ARWR vs ENVX Comparison
ARWR vs ENVX Comparison
Compare ARWR & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- ENVX
- Stock Information
- Founded
- ARWR 2003
- ENVX 2006
- Country
- ARWR United States
- ENVX United States
- Employees
- ARWR N/A
- ENVX N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- ENVX Industrial Machinery/Components
- Sector
- ARWR Health Care
- ENVX Miscellaneous
- Exchange
- ARWR Nasdaq
- ENVX Nasdaq
- Market Cap
- ARWR 1.7B
- ENVX 2.1B
- IPO Year
- ARWR 1993
- ENVX N/A
- Fundamental
- Price
- ARWR $12.74
- ENVX $7.34
- Analyst Decision
- ARWR Buy
- ENVX Strong Buy
- Analyst Count
- ARWR 11
- ENVX 11
- Target Price
- ARWR $41.44
- ENVX $20.64
- AVG Volume (30 Days)
- ARWR 1.6M
- ENVX 4.6M
- Earning Date
- ARWR 05-08-2025
- ENVX 04-30-2025
- Dividend Yield
- ARWR N/A
- ENVX N/A
- EPS Growth
- ARWR N/A
- ENVX N/A
- EPS
- ARWR N/A
- ENVX N/A
- Revenue
- ARWR $2,500,000.00
- ENVX $23,074,000.00
- Revenue This Year
- ARWR $4,380.43
- ENVX $53.25
- Revenue Next Year
- ARWR $58.72
- ENVX $337.98
- P/E Ratio
- ARWR N/A
- ENVX N/A
- Revenue Growth
- ARWR N/A
- ENVX 201.86
- 52 Week Low
- ARWR $12.20
- ENVX $5.70
- 52 Week High
- ARWR $30.41
- ENVX $18.68
- Technical
- Relative Strength Index (RSI)
- ARWR 27.27
- ENVX 36.63
- Support Level
- ARWR $14.69
- ENVX $7.73
- Resistance Level
- ARWR $15.65
- ENVX $9.07
- Average True Range (ATR)
- ARWR 0.78
- ENVX 0.51
- MACD
- ARWR -0.12
- ENVX 0.05
- Stochastic Oscillator
- ARWR 13.07
- ENVX 18.78
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
About ENVX Enovix Corporation
Enovix Corp is engaged in the business of advanced silicon-anode lithium-ion battery development and production. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable the widespread utilization of renewable energy.